The GR-ANXA1 pathway is a pathological player and a candidate target in epilepsy.
Zub E, Canet G, Garbelli R, Blaquiere M, Rossini L, Pastori C, Sheikh M, Reutelingsperger C, Klement W, de Bock F, Audinat E, Givalois L, Solito E, Marchi N.
Zub E, et al.
FASEB J. 2019 Dec;33(12):13998-14009. doi: 10.1096/fj.201901596R. Epub 2019 Oct 16.
FASEB J. 2019.
PMID: 31618599
The prospect of pharmacologically restoring or potentiating this endogenous anti-inflammatory mechanism as an add-on therapeutic strategy for specific forms of epilepsy is proposed.-Zub, E., Canet, G., Garbelli, R., Blaquiere, M., Rossini, L., Pastori, C., Sheikh, M …
The prospect of pharmacologically restoring or potentiating this endogenous anti-inflammatory mechanism as an add-on therapeutic strategy fo …